Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleClinical Investigation

Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis

Yasuhiko Ikari, Go Akamatsu, Keiichi Matsumoto, Tomohiko Yamane, Michio Senda, Kazuki Fukuchi and AMED Preclinical AD Study Investigators, and Alzheimer’s Disease Neuroimaging Initiative Investigators
Journal of Nuclear Medicine Technology April 2024, jnmt.123.267113; DOI: https://doi.org/10.2967/jnmt.123.267113
Yasuhiko Ikari
1Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan;
2Department of Medical Physics and Engineering, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Go Akamatsu
1Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan;
3National Institutes for Quantum Science and Technology, Chiba, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiichi Matsumoto
1Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan;
4Department of Radiological Technology, Faculty of Medical Science, Kyoto College of Medical Science, Nantan, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiko Yamane
1Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michio Senda
1Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuki Fukuchi
2Department of Medical Physics and Engineering, Division of Health Sciences, Osaka University Graduate School of Medicine, Suita, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Scheme of SUVR measurement methods: MUBADA/PERSI method (A) and tau meta-VOI/CGM method (B). MNI = Montreal Neurological Institute; WM = white matter.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Box plots of SUVR for each clinical category calculated with MUBADA/PERSI method and tau meta-VOI/CGM method. Combined data include 91 ADNI3 subjects and 15 AMED-PRE subjects (A), and separate analyses for ADNI3 data (B) and AMED-PRE data (C) are also shown.*Significant difference between 2 categories (P < 0.05).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Typical 18F-flortaucipir PET images in each clinical category. Numbers in each image indicate SUVRs computed with MUBADA/PERSI method (upper number) and with tau meta-VOI/CGM method (lower number). Reference value for color scale was defined by PERSI.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Histogram of white matter voxel radioactivity (kBq/mL) and process of extracting PERSI reference in 2 MCI[A+] cases (A and B). White matter histogram (WM hist) is fitted with 2 gaussian curves (G1 and G2), of which G2 corresponds to voxels with abnormal 18F-flortaucipir accumulation, if any, and spillover. Red rectangle indicates selected range derived from G1 to define reference white matter image, which is presented together with original PET image of same slice. MUBADA/PERSI SUVR is 1.16 (A) and 1.71 (B).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    VOI setting by MUBADA/PERSI and tau meta-VOI/CGM methods in representative late-MCI case. MUBADA/PERSI SUVR is 1.16, and tau meta-VOI/CGM SUVR is 1.46.

Tables

  • Figures
    • View popup
    TABLE 1.

    Demographics of Subjects Analyzed in This Study

    DatabaseCategorynAge (y)Clinical dementia ratingMini Mental State ExaminationAmyloid
    ADNI3 (n = 91)Normal2368–85027–30−
    Pre-AD2371–85024–30+
    MCI[A−]2365–820.525–30−
    MCI[A+]2265–850.524–30+
    AMED-PRE (n = 15)Normal965–80025–29−
    Pre-AD172029+
    MCI[A−]275–820.528–29−
    MCI[A+]373–840.526–28+
    • View popup
    TABLE 2.

    PET Scanner Models Used to Acquire 18F-Flortaucipir PET Images

    ADNI3AMED-PRE
    CategoryNormalPRE-ADMCI[A−]MCI[A+]NormalPRE-ADMCI[A−]MCI[A+]
    GE Discovery 690/7104312
    GE Discovery MI2
    GE Discovery MI DR11
    GE Discovery ST2111
    GE Discovery STE1362
    Siemens Biograph mCT3355
    Siemens Biograph TruePoint66221
    Siemens Biograph Vision1
    Philips Gemini TF2424
    Philips Ingenuity5243
    Philips Vereos1
    Shimadzu Eminence GX8123
    • View popup
    TABLE 3.

    Analysis Methods

    RegionParameterMUBADA/PERSITau meta-VOI/CGM
    TargetVOI nameMUBADA VOITau meta-VOI
    Image spaceMontreal Neurologic Institute spaceIndividual’s space
    Volume (cm3)1,306.363.7 ± 8.4*
    MethodStatistically derived area with MUBADA analysisAnatomically derived area with FreeSurfer
    AnatomicPosterior temporal, occipital, parietal, part of frontalAmygdala, entorhinal, fusiform, inferior temporal, middle temporal
    ReferenceVOI namePERSI VOICGM VOI
    Image spaceMontreal Neurologic Institute spaceIndividual’s space
    Volume (cm3)403.8 ± 50.6*103.9 ± 10.6*
    MethodProbabilistically derived area with PERSI analysis, individuallyAnatomically derived area with FreeSurfer
    AnatomicWhite matterCGM
    • ↵* VOI volume: mean ± SD [cm3] of each analysis.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 53 (1)
Journal of Nuclear Medicine Technology
Vol. 53, Issue 1
March 1, 2025
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis
Yasuhiko Ikari, Go Akamatsu, Keiichi Matsumoto, Tomohiko Yamane, Michio Senda, Kazuki Fukuchi, AMED Preclinical AD Study Investigators, and Alzheimer’s Disease Neuroimaging Initiative Investigators
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.267113; DOI: 10.2967/jnmt.123.267113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Improved Correlation of 18F-Flortaucipir PET SUVRs and Clinical Stages in the Alzheimer Disease Continuum with the MUBADA/PERSI-Based Analysis
Yasuhiko Ikari, Go Akamatsu, Keiichi Matsumoto, Tomohiko Yamane, Michio Senda, Kazuki Fukuchi, AMED Preclinical AD Study Investigators, and Alzheimer’s Disease Neuroimaging Initiative Investigators
Journal of Nuclear Medicine Technology Apr 2024, jnmt.123.267113; DOI: 10.2967/jnmt.123.267113
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An International Survey Investigating the Incidence and Management of Brown Fat Uptake on 18F-FDG PET/CT at Children’s Hospitals and Interventions for Mitigation
  • A Survey of Patient Experience During Molecular Breast Imaging
  • Safety and Efficacy of 90Y Selective Internal Radiation Therapy Using Glass Microspheres in Hepatocellular Carcinoma: A Southeast Asian Single-Institution Initial Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • tau PET
  • quantitative analysis
  • AD continuum
  • ADNI
  • MUBADA/PERSI
SNMMI

© 2025 SNMMI

Powered by HighWire